| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | TNRC18 MTA1 EPOP CENPF ASH1L PER1 CBX7 CHD1 CHD2 CHD3 ZFX SBNO2 DNMT3A CBX2 | 1.98e-06 | 739 | 83 | 14 | GO:0003682 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | SP100 SOST MTA1 CENPF BAZ2A NR4A2 PER1 NR4A3 NR4A1 TRIP12 MTDH DNMT3A | 4.93e-06 | 582 | 83 | 12 | GO:0140297 |
| GeneOntologyMolecularFunction | histone binding | 1.45e-05 | 265 | 83 | 8 | GO:0042393 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.65e-05 | 37 | 83 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 5.82e-05 | 417 | 83 | 9 | GO:0061629 | |
| GeneOntologyMolecularFunction | transcription factor binding | SP100 SOST MTA1 CENPF BAZ2A NR4A2 PER1 NR4A3 NR4A1 TRIP12 MTDH DNMT3A | 6.29e-05 | 753 | 83 | 12 | GO:0008134 |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 7.50e-05 | 20 | 83 | 3 | GO:0035259 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF384 MTA1 ZNF652 ZNF689 NR4A2 PER1 NR4A3 CHD2 NR4A1 ZNF324B ZNF524 MGA NEUROD6 ZFX DNMT3A | 1.68e-04 | 1244 | 83 | 15 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF384 MTA1 ZNF652 ZNF689 NR4A2 PER1 NR4A3 CHD2 NR4A1 ZNF324B ZNF524 MGA NEUROD6 ZFX DNMT3A | 2.12e-04 | 1271 | 83 | 15 | GO:0000987 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 4.93e-04 | 441 | 83 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 7.82e-04 | 262 | 83 | 6 | GO:0140097 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF384 MTA1 ZNF652 ZNF689 NR4A2 PER1 NR4A3 CHD2 NR4A1 ZNF324B ZNF524 MGA NEUROD6 ZFX DNMT3A | 9.09e-04 | 1459 | 83 | 15 | GO:0000977 |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.01e-03 | 614 | 83 | 9 | GO:0140657 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.10e-03 | 187 | 83 | 5 | GO:0016922 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.95e-03 | 127 | 83 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 2.00e-03 | 60 | 83 | 3 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 2.09e-03 | 61 | 83 | 3 | GO:0098531 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 3.10e-03 | 70 | 83 | 3 | GO:0003777 | |
| GeneOntologyBiologicalProcess | cellular response to corticotropin-releasing hormone stimulus | 1.16e-06 | 6 | 81 | 3 | GO:0071376 | |
| GeneOntologyBiologicalProcess | response to corticotropin-releasing hormone | 1.16e-06 | 6 | 81 | 3 | GO:0043435 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | MTA1 EPOP CENPF BAZ2A CECR2 TAF7L ASH1L PER1 CBX7 CHD1 CHD2 CHD3 TRIP12 DNMT3A CBX2 | 6.90e-06 | 999 | 81 | 15 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | MTA1 EPOP BAZ2A CECR2 ASH1L PER1 CBX7 CHD1 CHD2 CHD3 TRIP12 DNMT3A CBX2 | 4.36e-05 | 896 | 81 | 13 | GO:0006325 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | SP100 ZNF469 MTA1 CENPF BAZ2A NR4A2 PER1 CBX7 NR4A3 CHD3 ZC3H6 MTDH LARP7 SBNO2 DNMT3A CBX2 | 9.25e-05 | 1399 | 81 | 16 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | SP100 ZNF469 MTA1 CENPF BAZ2A NR4A2 PER1 CBX7 NR4A3 CHD3 ZC3H6 MTDH LARP7 SBNO2 DNMT3A CBX2 | 1.04e-04 | 1413 | 81 | 16 | GO:1902679 |
| GeneOntologyBiologicalProcess | chromatin remodeling | MTA1 EPOP BAZ2A CECR2 ASH1L PER1 CHD1 CHD2 CHD3 TRIP12 DNMT3A | 1.47e-04 | 741 | 81 | 11 | GO:0006338 |
| GeneOntologyCellularComponent | chromatin | MTA1 CENPF BAZ2A CECR2 NR4A2 CBX7 NR4A3 CHD1 CHD2 CHD3 NR4A1 MGA NEUROD6 ZC3H6 SLX4 ZFX DNMT3A CBX2 | 1.61e-05 | 1480 | 83 | 18 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | WDR74 SP100 MTA1 EPOP BAZ2A CECR2 GPATCH1 TAF7L CBX7 BOD1L1 CHD3 MGA SLX4 ATP5F1A LARP7 CBX2 | 8.91e-05 | 1377 | 83 | 16 | GO:0140513 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 5.82e-04 | 96 | 83 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | heterochromatin | 7.04e-04 | 101 | 83 | 4 | GO:0000792 | |
| Domain | AT_hook | 1.83e-11 | 27 | 81 | 7 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 1.83e-11 | 27 | 81 | 7 | IPR017956 | |
| Domain | HMGI/Y_DNA-bd_CS | 3.72e-09 | 31 | 81 | 6 | IPR000637 | |
| Domain | AT_hook | 5.70e-09 | 16 | 81 | 5 | PF02178 | |
| Domain | Chromodomain_CS | 1.11e-08 | 18 | 81 | 5 | IPR023779 | |
| Domain | Chromo_domain | 5.39e-08 | 24 | 81 | 5 | IPR023780 | |
| Domain | Nuc_orph_rcpt | 7.86e-08 | 3 | 81 | 3 | IPR003070 | |
| Domain | Chromo | 8.29e-08 | 26 | 81 | 5 | PF00385 | |
| Domain | CHROMO_1 | 1.23e-07 | 28 | 81 | 5 | PS00598 | |
| Domain | CHROMO_2 | 1.23e-07 | 28 | 81 | 5 | PS50013 | |
| Domain | Chromodomain-like | 2.49e-07 | 32 | 81 | 5 | IPR016197 | |
| Domain | Chromo/shadow_dom | 2.92e-07 | 33 | 81 | 5 | IPR000953 | |
| Domain | CHROMO | 2.92e-07 | 33 | 81 | 5 | SM00298 | |
| Domain | BAH | 1.26e-05 | 11 | 81 | 3 | SM00439 | |
| Domain | BAH | 1.26e-05 | 11 | 81 | 3 | PF01426 | |
| Domain | BAH | 1.26e-05 | 11 | 81 | 3 | PS51038 | |
| Domain | BAH_dom | 1.26e-05 | 11 | 81 | 3 | IPR001025 | |
| Domain | DUF4208 | 5.56e-05 | 3 | 81 | 2 | PF13907 | |
| Domain | DUF4208 | 5.56e-05 | 3 | 81 | 2 | SM01176 | |
| Domain | DUF4208 | 5.56e-05 | 3 | 81 | 2 | IPR025260 | |
| Domain | CBX7_C | 1.84e-04 | 5 | 81 | 2 | IPR033773 | |
| Domain | CBX7_C | 1.84e-04 | 5 | 81 | 2 | PF17218 | |
| Domain | SNF2_N | 3.56e-04 | 32 | 81 | 3 | IPR000330 | |
| Domain | SNF2_N | 3.56e-04 | 32 | 81 | 3 | PF00176 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 4.65e-04 | 35 | 81 | 3 | IPR002464 | |
| Domain | BROMODOMAIN_1 | 5.49e-04 | 37 | 81 | 3 | PS00633 | |
| Domain | DEAH_ATP_HELICASE | 5.94e-04 | 38 | 81 | 3 | PS00690 | |
| Domain | Bromodomain | 5.94e-04 | 38 | 81 | 3 | PF00439 | |
| Domain | BROMODOMAIN_2 | 7.44e-04 | 41 | 81 | 3 | PS50014 | |
| Domain | BROMO | 7.99e-04 | 42 | 81 | 3 | SM00297 | |
| Domain | Bromodomain | 7.99e-04 | 42 | 81 | 3 | IPR001487 | |
| Domain | - | 7.99e-04 | 42 | 81 | 3 | 1.20.920.10 | |
| Domain | zf-C4 | 1.04e-03 | 46 | 81 | 3 | PF00105 | |
| Domain | Znf_hrmn_rcpt | 1.04e-03 | 46 | 81 | 3 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 1.04e-03 | 46 | 81 | 3 | IPR001723 | |
| Domain | NUCLEAR_REC_DBD_2 | 1.04e-03 | 46 | 81 | 3 | PS51030 | |
| Domain | NUCLEAR_REC_DBD_1 | 1.04e-03 | 46 | 81 | 3 | PS00031 | |
| Domain | ZnF_C4 | 1.04e-03 | 46 | 81 | 3 | SM00399 | |
| Domain | - | 1.11e-03 | 47 | 81 | 3 | 1.10.565.10 | |
| Domain | HOLI | 1.18e-03 | 48 | 81 | 3 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 1.18e-03 | 48 | 81 | 3 | IPR000536 | |
| Domain | Hormone_recep | 1.18e-03 | 48 | 81 | 3 | PF00104 | |
| Domain | - | 1.94e-03 | 57 | 81 | 3 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 2.04e-03 | 58 | 81 | 3 | IPR013088 | |
| Domain | SAM_1 | 3.22e-03 | 68 | 81 | 3 | PF00536 | |
| Domain | Znf_FYVE_PHD | 3.83e-03 | 147 | 81 | 4 | IPR011011 | |
| Domain | PHD | 4.24e-03 | 75 | 81 | 3 | PF00628 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZNF384 MTA1 BAZ2A GPATCH1 FNBP4 KRI1 CHD1 BOD1L1 SCAF11 CHD3 RPS10P5 MGA TRIP12 MTDH SLX4 ATP5F1A CBX2 | 1.65e-10 | 954 | 86 | 17 | 36373674 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | PRR12 SCAF1 PPIG MTA1 EPOP CENPF BAZ2A GPATCH1 FNBP4 SCAF11 CHD2 CHD3 NR4A1 MGA TRIP12 MTDH ATP5F1A ZFX ZNF687 | 3.12e-10 | 1294 | 86 | 19 | 30804502 |
| Pubmed | 5.67e-09 | 157 | 86 | 8 | 30186101 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PRR12 SCAF1 ZNF384 TNRC18 POMGNT2 DNAJC14 EPOP RALGPS1 CASKIN1 HELZ2 PER1 TNK2 ZNF324B ZNF687 SBNO2 CBX2 | 1.16e-08 | 1105 | 86 | 16 | 35748872 |
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 25899083 | ||
| Pubmed | NR4A nuclear receptors support memory enhancement by histone deacetylase inhibitors. | 1.46e-08 | 3 | 86 | 3 | 22996661 | |
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 27159982 | ||
| Pubmed | Inhibition of adipocyte differentiation by Nur77, Nurr1, and Nor1. | 1.46e-08 | 3 | 86 | 3 | 18945812 | |
| Pubmed | The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss. | 1.46e-08 | 3 | 86 | 3 | 22143616 | |
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 16873729 | ||
| Pubmed | The orphan nuclear receptor Nur77 is a determinant of myofiber size and muscle mass in mice. | 1.46e-08 | 3 | 86 | 3 | 25605333 | |
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 15964844 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 28808448 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 25199433 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 24005216 | ||
| Pubmed | Minireview: What is Known about SUMOylation Among NR4A Family Members? | 1.46e-08 | 3 | 86 | 3 | 34437889 | |
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 24753204 | ||
| Pubmed | Differential regulation of Nr4a subfamily nuclear receptors following mast cell activation. | 1.46e-08 | 3 | 86 | 3 | 21621845 | |
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 10523643 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 20659174 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 36482877 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 25917081 | ||
| Pubmed | FGF-8 stimulates the expression of NR4A orphan nuclear receptors in osteoblasts. | 1.46e-08 | 3 | 86 | 3 | 18809462 | |
| Pubmed | NR4A transcription factors limit CAR T cell function in solid tumours. | 1.46e-08 | 3 | 86 | 3 | 30814732 | |
| Pubmed | The NR4A orphan nuclear receptors: mediators in metabolism and diseases. | 1.46e-08 | 3 | 86 | 3 | 25089663 | |
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 19465082 | ||
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 15910281 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZNF384 MTA1 BAZ2A CHD1 BOD1L1 SCAF11 CHD2 CHD3 MGA TRIP12 DNMT3A CBX2 | 3.45e-08 | 608 | 86 | 12 | 36089195 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 3.66e-08 | 283 | 86 | 9 | 30585729 | |
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 9326634 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 31152140 | ||
| Pubmed | Trained immunity induced by high-salt diet impedes stroke recovery. | 5.83e-08 | 4 | 86 | 3 | 37965920 | |
| Pubmed | Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis. | 5.83e-08 | 4 | 86 | 3 | 23334790 | |
| Pubmed | Evaluation of mRNA Expressions of TOX and NR4As in CD8+ T cells in Acute Leukemia. | 5.83e-08 | 4 | 86 | 3 | 37961948 | |
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 22789442 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 30089271 | ||
| Pubmed | Parathyroid hormone induces the NR4A family of nuclear orphan receptors in vivo. | 5.83e-08 | 4 | 86 | 3 | 15910753 | |
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 14525795 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 33665581 | ||
| Pubmed | SOST MTA1 FMN1 ZNF652 ASH1L BOD1L1 CHD2 CHD3 FAM171B MGA TRIP12 MTDH SLX4 ATP5F1A SBNO2 | 6.37e-08 | 1084 | 86 | 15 | 11544199 | |
| Pubmed | 1.45e-07 | 5 | 86 | 3 | 15155786 | ||
| Pubmed | Suppression of Th2 and Tfh immune reactions by Nr4a receptors in mature T reg cells. | 1.45e-07 | 5 | 86 | 3 | 26304965 | |
| Pubmed | 1.45e-07 | 5 | 86 | 3 | 8961274 | ||
| Pubmed | 2.56e-07 | 469 | 86 | 10 | 27634302 | ||
| Pubmed | 2.90e-07 | 6 | 86 | 3 | 25809189 | ||
| Pubmed | 3.11e-07 | 57 | 86 | 5 | 17296600 | ||
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 3.16e-07 | 109 | 86 | 6 | 33554859 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SCAF1 PPIG MTA1 BAZ2A FNBP4 HELZ2 SCAF11 CHD3 TRIP12 ADARB1 ZFX ZNF687 | 4.60e-07 | 774 | 86 | 12 | 15302935 |
| Pubmed | 5.19e-07 | 282 | 86 | 8 | 23667531 | ||
| Pubmed | SCAF1 SP100 ZNF469 MTA1 BAZ2A CECR2 TAF7L ASH1L PER1 CHD3 PCMTD1 MGA LARP7 ZNF687 | 5.98e-07 | 1116 | 86 | 14 | 31753913 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TNRC18 CAMK2N1 NEIL1 GALNT11 RALGPS1 ASH1L FNBP4 EVC RTN4RL1 TNK2 BOD1L1 SCAF11 CHD2 CHD3 ADARB1 SBNO2 | 6.69e-07 | 1489 | 86 | 16 | 28611215 |
| Pubmed | Nur77 is phosphorylated in cells by RSK in response to mitogenic stimulation. | 8.10e-07 | 8 | 86 | 3 | 16223362 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 8.32e-07 | 410 | 86 | 9 | 26949251 | |
| Pubmed | 1.24e-06 | 75 | 86 | 5 | 25593309 | ||
| Pubmed | WDR74 SCAF1 PPIG FNBP4 HELZ2 WDR55 KRI1 SCAF11 CHD2 CHD3 TRIP12 MTDH ATP5F1A LARP7 CBX2 | 1.26e-06 | 1371 | 86 | 15 | 36244648 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 1.68e-06 | 330 | 86 | 8 | 33301849 | |
| Pubmed | 3.10e-06 | 251 | 86 | 7 | 28077445 | ||
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 3.88e-06 | 495 | 86 | 9 | 27705803 | |
| Pubmed | 5.95e-06 | 103 | 86 | 5 | 32744500 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 32571914 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 34248958 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 30111648 | ||
| Pubmed | CHD1 and CHD2 are positive regulators of HIV-1 gene expression. | 6.04e-06 | 2 | 86 | 2 | 25297984 | |
| Pubmed | Differential roles for Nr4a1 and Nr4a2 in object location vs. object recognition long-term memory. | 6.04e-06 | 2 | 86 | 2 | 23161447 | |
| Pubmed | The orphan nuclear receptor Nor1/Nr4a3 is a negative regulator of β-cell mass. | 6.04e-06 | 2 | 86 | 2 | 30696767 | |
| Pubmed | Fast or Slow, Either Head Can Start the Processive Run of Kinesin-2 KIF3AC. | 6.04e-06 | 2 | 86 | 2 | 26710851 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 20411565 | ||
| Pubmed | Nuclear receptors Nur77 and Nurr1 modulate mesenchymal stromal cell migration. | 6.04e-06 | 2 | 86 | 2 | 21480782 | |
| Pubmed | NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes. | 6.04e-06 | 2 | 86 | 2 | 28249906 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 20668010 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 15486232 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 36469101 | ||
| Pubmed | The nuclear orphan receptor NR4A1 and NR4A3 as tumor suppressors in hematologic neoplasms. | 6.04e-06 | 2 | 86 | 2 | 25410408 | |
| Pubmed | Subcellular expression pattern and clinical significance of CBX2 and CBX7 in breast cancer subtypes. | 6.04e-06 | 2 | 86 | 2 | 37553450 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 19153266 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 38474099 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 23247046 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 8798555 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 29700290 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 15292355 | ||
| Pubmed | Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia. | 6.04e-06 | 2 | 86 | 2 | 17515897 | |
| Pubmed | Reduced NR4A gene dosage leads to mixed myelodysplastic/myeloproliferative neoplasms in mice. | 6.04e-06 | 2 | 86 | 2 | 21205929 | |
| Pubmed | Characterization of the KIF3C neural kinesin-like motor from mouse. | 6.04e-06 | 2 | 86 | 2 | 9450952 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 32341238 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 33400401 | ||
| Pubmed | Identification of a new brain-specific transcription factor, NURR1. | 6.04e-06 | 2 | 86 | 2 | 1491694 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 34415548 | ||
| Pubmed | Spontaneous allelic variant in deafness-blindness gene Ush1g resulting in an expanded phenotype. | 6.04e-06 | 2 | 86 | 2 | 37328946 | |
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 28637666 | ||
| Pubmed | 6.44e-06 | 396 | 86 | 8 | 26687479 | ||
| Pubmed | TIF1beta/KAP-1 is a coactivator of the orphan nuclear receptor NGFI-B/Nur77. | 6.50e-06 | 15 | 86 | 3 | 19321449 | |
| Pubmed | 7.98e-06 | 689 | 86 | 10 | 36543142 | ||
| Pubmed | 7.99e-06 | 16 | 86 | 3 | 28170423 | ||
| Pubmed | Maternal bile acid transporter deficiency promotes neonatal demise. | 1.43e-05 | 59 | 86 | 4 | 26416771 | |
| Pubmed | PRR12 SCAF1 MTA1 BAZ2A ZNF652 HELZ2 WDR55 CHD1 SCAF11 CHD2 ATP5F1A LARP7 ZNF687 TWF1 | 1.75e-05 | 1497 | 86 | 14 | 31527615 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 35604009 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 23552735 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 21979916 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 25092869 | ||
| Pubmed | Kinesin-2 KIF3AC and KIF3AB Can Drive Long-Range Transport along Microtubules. | 1.81e-05 | 3 | 86 | 2 | 26445448 | |
| Interaction | NUP43 interactions | SCAF1 MTA1 BAZ2A GPATCH1 ASH1L KRI1 CHD1 BOD1L1 CHD3 MGA TRIP12 SLX4 LARP7 ZFX ZNF687 | 4.82e-08 | 625 | 85 | 15 | int:NUP43 |
| Interaction | TERF2IP interactions | SP100 KBTBD6 BAZ2A CHD1 BOD1L1 SCAF11 CHD3 MGA TRIP12 SLX4 LARP7 ZNF687 DNMT3A CBX2 | 7.23e-08 | 552 | 85 | 14 | int:TERF2IP |
| Interaction | H3-3A interactions | ZNF384 MTA1 CCDC71 BAZ2A ASH1L CBX7 CHD1 BOD1L1 SCAF11 CHD2 CHD3 MGA TRIP12 DNMT3A CBX2 | 4.95e-07 | 749 | 85 | 15 | int:H3-3A |
| Interaction | SRSF5 interactions | WDR74 SCAF1 PPIG NEIL1 ZNF689 KRI1 TNK2 SCAF11 CHD3 ADARB1 MTDH LARP7 | 6.93e-07 | 474 | 85 | 12 | int:SRSF5 |
| Interaction | SMC5 interactions | ZNF384 MTA1 BAZ2A GPATCH1 FNBP4 KRI1 CHD1 BOD1L1 SCAF11 CHD3 RPS10P5 MGA TRIP12 MTDH SLX4 ATP5F1A CBX2 | 7.69e-07 | 1000 | 85 | 17 | int:SMC5 |
| Interaction | SNRNP40 interactions | SCAF1 ZNF384 MTA1 BAZ2A GPATCH1 KRI1 CHD1 SCAF11 CHD3 MGA MTDH LARP7 CBX2 | 2.54e-06 | 637 | 85 | 13 | int:SNRNP40 |
| Interaction | SSRP1 interactions | SCAF1 ZNF384 MTA1 CCDC71 CHD1 SCAF11 CHD2 CHD3 ADARB1 MTDH LARP7 ZNF687 CBX2 | 5.61e-06 | 685 | 85 | 13 | int:SSRP1 |
| Interaction | H3C3 interactions | ZNF384 MTA1 BAZ2A CHD1 BOD1L1 SCAF11 CHD3 MGA TRIP12 DNMT3A CBX2 | 7.28e-06 | 495 | 85 | 11 | int:H3C3 |
| Interaction | TWIST1 interactions | 7.63e-06 | 170 | 85 | 7 | int:TWIST1 | |
| Interaction | CHD4 interactions | MTA1 BAZ2A FNBP4 KRI1 SCAF11 CHD3 NR4A1 ZNF524 TRIP12 ADARB1 MTDH SLX4 ATP5F1A LARP7 ZNF687 | 7.91e-06 | 938 | 85 | 15 | int:CHD4 |
| Interaction | KPNA1 interactions | 1.71e-05 | 351 | 85 | 9 | int:KPNA1 | |
| Interaction | ZNF330 interactions | 1.81e-05 | 446 | 85 | 10 | int:ZNF330 | |
| Interaction | PYHIN1 interactions | 2.00e-05 | 358 | 85 | 9 | int:PYHIN1 | |
| Interaction | H3C1 interactions | TNRC18 MTA1 BAZ2A ASH1L CBX7 WDR55 KRI1 CHD1 CHD3 MGA TRIP12 LARP7 DNMT3A CBX2 | 2.27e-05 | 901 | 85 | 14 | int:H3C1 |
| Interaction | H2BC8 interactions | ZNF384 KBTBD6 BAZ2A CHD1 SCAF11 CHD3 MGA TRIP12 ZNF687 DNMT3A CBX2 | 2.97e-05 | 576 | 85 | 11 | int:H2BC8 |
| Interaction | CENPA interactions | 3.00e-05 | 377 | 85 | 9 | int:CENPA | |
| Interaction | NANOG interactions | MTA1 CENPF CECR2 SCAF11 ZNF524 PCMTD1 MGA TRIP12 DNMT3A CBX2 | 3.45e-05 | 481 | 85 | 10 | int:NANOG |
| Interaction | H2AX interactions | TNRC18 MTA1 BAZ2A NEIL1 ZNF689 KRI1 ADARB1 LARP7 ZNF687 DNMT3A CBX2 | 3.87e-05 | 593 | 85 | 11 | int:H2AX |
| Interaction | RPL7 interactions | 4.10e-05 | 491 | 85 | 10 | int:RPL7 | |
| Interaction | ZNF768 interactions | 4.30e-05 | 151 | 85 | 6 | int:ZNF768 | |
| Interaction | CSNK2A1 interactions | MTA1 NEIL1 FNBP4 CBX7 WDR55 CHD3 NR4A1 MGA MTDH SHANK3 ATP5F1A LARP7 ZNF687 CBX2 | 4.35e-05 | 956 | 85 | 14 | int:CSNK2A1 |
| Interaction | OASL interactions | 4.39e-05 | 223 | 85 | 7 | int:OASL | |
| Interaction | RPL3 interactions | WDR74 NEIL1 WDR55 KRI1 CHD3 ZNF324B TRIP12 ADARB1 MTDH SHANK3 SLX4 LARP7 | 4.89e-05 | 722 | 85 | 12 | int:RPL3 |
| Interaction | RPL19 interactions | WDR74 SCAF1 ZNF384 SP100 WDR55 KRI1 CHD3 ADARB1 MTDH SLX4 LARP7 | 7.48e-05 | 638 | 85 | 11 | int:RPL19 |
| Interaction | NIFK interactions | 8.43e-05 | 431 | 85 | 9 | int:NIFK | |
| Interaction | MKI67 interactions | WDR74 ZNF384 DNAH3 CENPF BAZ2A KRI1 SCAF11 CHD3 MGA ADARB1 SLX4 | 8.59e-05 | 648 | 85 | 11 | int:MKI67 |
| Interaction | DHX57 interactions | 9.47e-05 | 252 | 85 | 7 | int:DHX57 | |
| Interaction | ZBTB2 interactions | 1.17e-04 | 450 | 85 | 9 | int:ZBTB2 | |
| Interaction | TOP3B interactions | PRR12 SCAF1 ZNF384 TNRC18 POMGNT2 DNAJC14 EPOP CENPF RALGPS1 CASKIN1 HELZ2 PER1 TNK2 ZNF324B ZNF687 SBNO2 CBX2 | 1.17e-04 | 1470 | 85 | 17 | int:TOP3B |
| Interaction | CBX5 interactions | 1.29e-04 | 356 | 85 | 8 | int:CBX5 | |
| Interaction | XRCC6 interactions | TNRC18 MTA1 BAZ2A GPATCH1 KRI1 BOD1L1 SCAF11 CHD3 MGA TRIP12 ADARB1 MTDH LARP7 | 1.31e-04 | 928 | 85 | 13 | int:XRCC6 |
| Interaction | NPM1 interactions | WDR74 SCAF1 CENPF CASKIN1 WDR55 KRI1 CHD1 CHD3 ADARB1 MTDH SHANK3 SLX4 ATP5F1A LARP7 CBX2 | 1.36e-04 | 1201 | 85 | 15 | int:NPM1 |
| Interaction | H2BC21 interactions | PRR12 MTA1 CCDC71 CENPF FNBP4 SCAF11 TRIP12 ADARB1 LARP7 ZNF687 CBX2 | 1.61e-04 | 696 | 85 | 11 | int:H2BC21 |
| Interaction | RNF151 interactions | 1.73e-04 | 123 | 85 | 5 | int:RNF151 | |
| Interaction | UHRF2 interactions | 2.02e-04 | 200 | 85 | 6 | int:UHRF2 | |
| Interaction | USP36 interactions | 2.11e-04 | 599 | 85 | 10 | int:USP36 | |
| Interaction | CBX1 interactions | 2.16e-04 | 288 | 85 | 7 | int:CBX1 | |
| Interaction | POLR1G interactions | 2.18e-04 | 489 | 85 | 9 | int:POLR1G | |
| Interaction | YTHDC2 interactions | 2.31e-04 | 205 | 85 | 6 | int:YTHDC2 | |
| Interaction | RPF1 interactions | 2.41e-04 | 132 | 85 | 5 | int:RPF1 | |
| Interaction | ZNF827 interactions | 2.44e-04 | 29 | 85 | 3 | int:ZNF827 | |
| Interaction | MEGF11 interactions | 2.61e-04 | 6 | 85 | 2 | int:MEGF11 | |
| Interaction | SRSF6 interactions | 2.68e-04 | 503 | 85 | 9 | int:SRSF6 | |
| Interaction | BCOR interactions | 2.88e-04 | 302 | 85 | 7 | int:BCOR | |
| Interaction | C7orf50 interactions | 3.21e-04 | 218 | 85 | 6 | int:C7orf50 | |
| Interaction | CIT interactions | SCAF1 ZNF384 CENPF ASH1L KRI1 CHD1 BOD1L1 SCAF11 CHD2 CHD3 PCMTD1 TRIP12 MTDH SHANK3 ATP5F1A ZNF687 | 3.27e-04 | 1450 | 85 | 16 | int:CIT |
| Interaction | PLCD4 interactions | 3.29e-04 | 32 | 85 | 3 | int:PLCD4 | |
| Interaction | CHD3 interactions | MTA1 EPOP FNBP4 KRI1 SCAF11 CHD3 NR4A1 ADARB1 MTDH ATP5F1A ZNF687 | 3.31e-04 | 757 | 85 | 11 | int:CHD3 |
| Interaction | RBM19 interactions | 3.45e-04 | 221 | 85 | 6 | int:RBM19 | |
| Interaction | MEN1 interactions | PRR12 ZNF384 BAZ2A GPATCH1 FNBP4 KRI1 CHD1 BOD1L1 SCAF11 CHD3 TRIP12 MTDH ZNF687 | 3.59e-04 | 1029 | 85 | 13 | int:MEN1 |
| Interaction | PARP1 interactions | SCAF1 ZNF384 MTA1 CECR2 KRI1 CHD1 SCAF11 CHD3 MGA TRIP12 SLX4 ATP5F1A LARP7 DNMT3A CBX2 | 3.66e-04 | 1316 | 85 | 15 | int:PARP1 |
| Interaction | SMC1A interactions | 3.83e-04 | 418 | 85 | 8 | int:SMC1A | |
| Interaction | DSCR9 interactions | 3.96e-04 | 147 | 85 | 5 | int:DSCR9 | |
| Interaction | RPL11 interactions | WDR74 KBTBD6 NEIL1 ZNF689 CHD3 TRIP12 ADARB1 MTDH SLX4 LARP7 | 4.13e-04 | 652 | 85 | 10 | int:RPL11 |
| Interaction | RPS27A interactions | 4.26e-04 | 536 | 85 | 9 | int:RPS27A | |
| Interaction | H1-4 interactions | 4.33e-04 | 656 | 85 | 10 | int:H1-4 | |
| Interaction | CTR9 interactions | 4.57e-04 | 233 | 85 | 6 | int:CTR9 | |
| Interaction | HIC1 interactions | 4.68e-04 | 36 | 85 | 3 | int:HIC1 | |
| Interaction | NOL12 interactions | 4.75e-04 | 153 | 85 | 5 | int:NOL12 | |
| Interaction | PHC1 interactions | 4.81e-04 | 86 | 85 | 4 | int:PHC1 | |
| Interaction | H1-2 interactions | 4.88e-04 | 666 | 85 | 10 | int:H1-2 | |
| Interaction | RPL14 interactions | 5.41e-04 | 554 | 85 | 9 | int:RPL14 | |
| Interaction | MDK interactions | 5.96e-04 | 91 | 85 | 4 | int:MDK | |
| Interaction | ASF1A interactions | 6.49e-04 | 249 | 85 | 6 | int:ASF1A | |
| Interaction | ACTC1 interactions | 6.71e-04 | 694 | 85 | 10 | int:ACTC1 | |
| Interaction | RPL17 interactions | 6.71e-04 | 571 | 85 | 9 | int:RPL17 | |
| Interaction | BEND7 interactions | 6.73e-04 | 94 | 85 | 4 | int:BEND7 | |
| GeneFamily | PHD finger proteins | 1.29e-04 | 90 | 52 | 4 | 88 | |
| GeneFamily | Chromobox family | 2.25e-04 | 8 | 52 | 2 | 976 | |
| GeneFamily | Nuclear hormone receptors | 3.77e-04 | 49 | 52 | 3 | 71 | |
| GeneFamily | PHD finger proteins|NuRD complex | 5.26e-04 | 12 | 52 | 2 | 1305 | |
| GeneFamily | Sterile alpha motif domain containing | 2.07e-03 | 88 | 52 | 3 | 760 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 2.33e-03 | 25 | 52 | 2 | 775 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.27e-03 | 718 | 52 | 7 | 28 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 7.74e-03 | 46 | 52 | 2 | 622 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | PPIG ZNF652 ASH1L FNBP4 NR4A2 CBX7 KRI1 TNK2 CHD1 BOD1L1 SCAF11 CHD2 CHD3 TRIP12 ADARB1 ZC3H6 MTDH SBNO2 | 1.12e-06 | 1492 | 85 | 18 | M40023 |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 4.05e-06 | 200 | 85 | 7 | M9188 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 3.26e-05 | 276 | 85 | 7 | M41128 | |
| Coexpression | GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_UP | 4.72e-05 | 199 | 85 | 6 | M7885 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 4.72e-05 | 199 | 85 | 6 | M9180 | |
| Coexpression | GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_DN | 4.72e-05 | 199 | 85 | 6 | M9195 | |
| Coexpression | GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_DN | 4.85e-05 | 200 | 85 | 6 | M5986 | |
| Coexpression | GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP | 4.85e-05 | 200 | 85 | 6 | M7172 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CAMK2N1 KBTBD6 RALGPS1 CABP4 CASKIN1 NXPH1 TNK2 BOD1L1 CHD3 KIF3C FAM171B SHANK3 KIF3A | 5.51e-05 | 1106 | 85 | 13 | M39071 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN | SP100 BAZ2A ZNF689 NR4A2 PER1 NR4A3 SCAF11 CHD2 LARP7 ZFX TWF1 | 8.80e-05 | 844 | 85 | 11 | M41129 |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-09 | 188 | 85 | 8 | 5e13725136114e42d3b59647cf25e0f3c53abb54 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.76e-09 | 200 | 85 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 4.76e-09 | 200 | 85 | 8 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.19e-08 | 187 | 85 | 7 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | Posterior_cortex|World / BrainAtlas - Mouse McCarroll V32 | 6.15e-07 | 159 | 85 | 6 | 18e9fe2efbe0bca7c3990f3b12b6f549e2c1263a | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-06 | 182 | 85 | 6 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-06 | 188 | 85 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.69e-06 | 189 | 85 | 6 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-06 | 190 | 85 | 6 | 92456f6f7eced6e4c4371f495254a65d061c8d0b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.79e-06 | 191 | 85 | 6 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 2.14e-06 | 197 | 85 | 6 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.27e-06 | 199 | 85 | 6 | 77b4aa00f14b86ef5db0490be98787e063979541 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.19e-06 | 125 | 85 | 5 | 5626eb77e542fcc87cd1fdf65f8623f3249ff9db | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.44e-05 | 161 | 85 | 5 | 78cc5bc488bc47726195a649946d414e6bfabf94 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.48e-05 | 162 | 85 | 5 | 0fa93efc9c005d1e649b3f7069ae8641d6e41ed8 | |
| ToppCell | IIF|World / Disease, Lineage and Cell Type | 1.81e-05 | 169 | 85 | 5 | ebf726f725079317ad67c2f754748b4112607277 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 183 | 85 | 5 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 2.66e-05 | 183 | 85 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 183 | 85 | 5 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 3.10e-05 | 189 | 85 | 5 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-naive_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.26e-05 | 191 | 85 | 5 | a073d58154c801ec499fd969f42b7f1ee7f15d79 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 3.34e-05 | 192 | 85 | 5 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.42e-05 | 193 | 85 | 5 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 3.42e-05 | 193 | 85 | 5 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 3.51e-05 | 194 | 85 | 5 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 195 | 85 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.69e-05 | 196 | 85 | 5 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.69e-05 | 196 | 85 | 5 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.78e-05 | 197 | 85 | 5 | fd5fdc5289d681d59ff22d72e4de6e74c6c7aac6 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 3.78e-05 | 197 | 85 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.87e-05 | 198 | 85 | 5 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_only / Treatment groups by lineage, cell group, cell type | 3.87e-05 | 198 | 85 | 5 | d205dfcfe1f20e1e21bf84759e723d9e6e610a5c | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.87e-05 | 198 | 85 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.87e-05 | 198 | 85 | 5 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.96e-05 | 199 | 85 | 5 | d3f36ede2fade550ec8f21a0448e71e1ff579ee2 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 3.96e-05 | 199 | 85 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | lymphoid-NK_cell-NK_cell|NK_cell / Lineage, cell class and subclass | 3.96e-05 | 199 | 85 | 5 | 945fbf5845403a8b22d04963f50ad69c414b6153 | |
| ToppCell | myeloid-Dendritic_cell-Conventional_dendritic_cell|myeloid / Lineage, cell class and subclass | 3.96e-05 | 199 | 85 | 5 | 1e7ce1a1d6a7af18351d64b7a5334efa6dd9abc5 | |
| ToppCell | myeloid-Dendritic_cell|myeloid / Lineage, cell class and subclass | 3.96e-05 | 199 | 85 | 5 | b81c0a40481f1006ac4aa8759af95448cb5fc2e6 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.06e-05 | 200 | 85 | 5 | 750ff51c9de08aecec230f4a402e0bf5a789f24c | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.06e-05 | 200 | 85 | 5 | f7c3a8f5ac156c05ad7335d6d142c154c7d86449 | |
| ToppCell | MS-IIF|MS / Disease, condition lineage and cell class | 4.06e-05 | 200 | 85 | 5 | 221f59edcfc18baece13184c2552d26022228146 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 4.06e-05 | 200 | 85 | 5 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic-non-classical_monocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.47e-05 | 108 | 85 | 4 | 695ed3f8cf637d767a6d79b0309d5ee82dfd063f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Rrad|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.42e-04 | 138 | 85 | 4 | b3a040c5d0e1cc94d9b19155bca8700edba2d243 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.42e-04 | 138 | 85 | 4 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.54e-04 | 141 | 85 | 4 | 737237db115721524c44ea4c55aed000e1b00ee5 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.54e-04 | 141 | 85 | 4 | c14f84bc3921cafbce6fa7f7163ecf3cd9cdf073 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.C1ql2_(red_nucleus,_magnocellular/parvicellular_(RMC/RPC))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.59e-04 | 55 | 85 | 3 | 0e90e59184916d1c51b62c9b97498365173cb271 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.C1ql2_(red_nucleus,_magnocellular/parvicellular_(RMC/RPC))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.59e-04 | 55 | 85 | 3 | 9ea9e69d0f6cc4317df3538ee030a703e62c644f | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.62e-04 | 143 | 85 | 4 | 091708a47ac55c6585923ee30190ff296fa87f6f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Met|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.71e-04 | 145 | 85 | 4 | 8abbc781f5f69f039617c29a5589d7b6950c2c40 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-4|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.95e-04 | 150 | 85 | 4 | bcb99c6fa81052556ab30f9db5875fccf1ae724b | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.05e-04 | 152 | 85 | 4 | b6a7453fbf9f898e4f222b215907c9a110baa2f6 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.21e-04 | 155 | 85 | 4 | 77ae0b8d30bc3db4a73fd5340f99691a73d2684f | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.26e-04 | 156 | 85 | 4 | 029ba0832ee9c4a2c85620e4df2260e02d86b45c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.26e-04 | 156 | 85 | 4 | 0f54d62c0fc08bbdd5ac743b2d5d748c3d1e6ef9 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.26e-04 | 156 | 85 | 4 | 5df19a235843829f5a1a90ca21b0964ef8b4e115 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.26e-04 | 156 | 85 | 4 | af47a4b17342bdb3cb62d7e2d52a81168e588629 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Pld5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.43e-04 | 159 | 85 | 4 | a082e770fa757c4a1d3ed13d53f83297e36faf05 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.49e-04 | 160 | 85 | 4 | 8a41e2c96e0e170ac35daf6c403bf961b8d7c30b | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.49e-04 | 160 | 85 | 4 | d6678996e12eaf2b735f1dfae32418cb2fabf268 | |
| ToppCell | PBMC-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters | 2.49e-04 | 160 | 85 | 4 | 4dac64e58d9366c399f3d830848ccb720d400be7 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.49e-04 | 160 | 85 | 4 | c8dc575562b463fd30832d322c28006f18f7ab9c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.68e-04 | 163 | 85 | 4 | 1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.68e-04 | 163 | 85 | 4 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.68e-04 | 163 | 85 | 4 | 1e8730d75cccf7292010683ab4e81a69d8e3bfa9 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Plasma_cells-IgM_plasma_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.80e-04 | 165 | 85 | 4 | 6e8370b8e747d8ef44a2413a993291a3cd83a77c | |
| ToppCell | PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.80e-04 | 165 | 85 | 4 | 66f0364098d82629aa2ec1dfe0c5ad23de7c2c12 | |
| ToppCell | BAL-Severe-cDC_5|Severe / Compartment, Disease Groups and Clusters | 3.00e-04 | 168 | 85 | 4 | 857a80c217a5513553460798a625612031bc7bb7 | |
| ToppCell | COVID-19-Myeloid-MoAM5,_CCL3L1|Myeloid / Condition, Lineage and Cell class | 3.00e-04 | 168 | 85 | 4 | ea465152ea31391b63c02425beafa9a4f51f6703 | |
| ToppCell | -Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 3.07e-04 | 169 | 85 | 4 | 8ebe9a88111c53a09c25a7b6a164a0a17880458d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.07e-04 | 169 | 85 | 4 | 0867528101767fc65e93b3561480bf830c50368d | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.43e-04 | 174 | 85 | 4 | 41eb0a214a8b4015a26311f77061c8147144f0e7 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-Tfh|blood / Manually curated celltypes from each tissue | 3.50e-04 | 175 | 85 | 4 | d7e24ac683ff36f7ce3d1151353d3d4a6f2b63bf | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.58e-04 | 176 | 85 | 4 | a31d7532f8c055d4e62bbaa78d819f2495bfee00 | |
| ToppCell | systemic_lupus_erythematosus-managed|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.58e-04 | 176 | 85 | 4 | e406a05345461d23cba21c5444223c937143e96a | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.66e-04 | 177 | 85 | 4 | 3a150dcaefa342d49968b42c7cdb1fbb633adcd0 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.66e-04 | 177 | 85 | 4 | c9e5820ff0bc7ad1adcfb2651713fdfc58bced56 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-04 | 178 | 85 | 4 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.74e-04 | 178 | 85 | 4 | 89f0537459a321ded956bf70ad56fefc0854f8b0 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.82e-04 | 179 | 85 | 4 | 42f3c040f504a91cc69292d39d22b5715c12526f | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.82e-04 | 179 | 85 | 4 | 063c05753ef1b4a18bc1ebbcae62c8cd25d11070 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 3.82e-04 | 179 | 85 | 4 | 431e1b29015ec817f778499106d24b19cfc825ae | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.82e-04 | 179 | 85 | 4 | 3d3716078afdb9a89ddfadb3197cd1b52fa770be | |
| ToppCell | ASK454-Endothelial-Lymphatic|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.82e-04 | 179 | 85 | 4 | fd84a79f76a01c0377dff5b20016b004d369f96f | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Dendritic_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-04 | 180 | 85 | 4 | 710526abedc8e0f9ba19ad69220df4c9468ada8f | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-04 | 180 | 85 | 4 | b6f44fdedc33b7d93b0074e8e9c8cc32009d4c4d | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.06e-04 | 182 | 85 | 4 | f231e86524b628e6e11ac33d5c34be99d454a92a | |
| ToppCell | Monocytes-IL1B+_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.32e-04 | 185 | 85 | 4 | cbe54b605f417a01b3b5d2ec75565ee3b5a9ba06 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-04 | 186 | 85 | 4 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | PBMC-Mild-cDC_5|Mild / Compartment, Disease Groups and Clusters | 4.50e-04 | 187 | 85 | 4 | 0afef5baf3752314dbfb024790347d5e51f9b84b | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.59e-04 | 188 | 85 | 4 | d1a4cd4db95d8d32b79156290f7867f32824cc87 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.68e-04 | 189 | 85 | 4 | b0244a9d1b5c8ad4708750b691184f3491b13900 | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 4.68e-04 | 189 | 85 | 4 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 4.68e-04 | 189 | 85 | 4 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | ILEUM|World / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.78e-04 | 190 | 85 | 4 | 4395dbd18c14d491f5066a2ddac438a16b1fd7c3 | |
| ToppCell | PBMC-Control-cDC_6|Control / Compartment, Disease Groups and Clusters | 4.97e-04 | 192 | 85 | 4 | 41a7201febb7d88a39e4ee64df04cce18c691df8 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.97e-04 | 192 | 85 | 4 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 5.07e-04 | 193 | 85 | 4 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 6.35e-05 | 152 | 81 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Autism Spectrum Disorders | 9.01e-05 | 85 | 81 | 4 | C1510586 | |
| Disease | Neurodevelopmental Disorders | 1.28e-04 | 93 | 81 | 4 | C1535926 | |
| Disease | Bell's palsy | 1.83e-04 | 102 | 81 | 4 | EFO_0007167 | |
| Disease | Intellectual Disability | 2.31e-04 | 447 | 81 | 7 | C3714756 | |
| Disease | Polydactyly | 3.09e-04 | 117 | 81 | 4 | C0152427 | |
| Disease | Insulin Sensitivity | 6.09e-04 | 60 | 81 | 3 | C0920563 | |
| Disease | Insulin Resistance | 6.09e-04 | 60 | 81 | 3 | C0021655 | |
| Disease | thyroid gland papillary carcinoma (is_marker_for) | 6.63e-04 | 14 | 81 | 2 | DOID:3969 (is_marker_for) | |
| Disease | Abnormal behavior | 8.71e-04 | 16 | 81 | 2 | C0233514 | |
| Disease | thyroxine measurement | 1.56e-03 | 83 | 81 | 3 | EFO_0005130 | |
| Disease | mean reticulocyte volume | 1.57e-03 | 799 | 81 | 8 | EFO_0010701 | |
| Disease | Seckel syndrome | 1.66e-03 | 22 | 81 | 2 | C0265202 | |
| Disease | Dwarfism | 2.14e-03 | 25 | 81 | 2 | C0013336 | |
| Disease | Acute monocytic leukemia | 2.32e-03 | 26 | 81 | 2 | C0023465 | |
| Disease | Sezary Syndrome | 2.50e-03 | 27 | 81 | 2 | C0036920 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VPLGPRKKILGAVRR | 431 | Q495M9 | |
| LPKPGKRLKQRRFRR | 206 | Q5SNV9 | |
| LSVSPFPKKRGRPKR | 881 | Q9NR48 | |
| AGKPKKARGPILRGR | 71 | A0A1B0GTR3 | |
| AGKPKKARGPILRGR | 71 | P0DPH9 | |
| RKVGRPGRKRKHPPV | 46 | Q9Y6K1 | |
| RGRGRPPKVKITELL | 671 | Q9UIF9 | |
| GKRPKKRGRPRTIPR | 1106 | O14646 | |
| KTGKRRGRPPKRKKL | 196 | Q9BXF3 | |
| KGPIGSKTRRRVGLK | 161 | P25705 | |
| DFKRLGLRKPGLPRG | 531 | Q07912 | |
| ARPKRKGKCARRTPI | 396 | Q86UN2 | |
| GPLRRKTLLKEGRKP | 436 | Q5JS13 | |
| ALPQKRTKRKGRGGR | 171 | Q68DA7 | |
| SLKGRRGRLPSKPKQ | 341 | P22736 | |
| RLLQRPRPGKAKLLG | 21 | Q8WXD9 | |
| GEAKPKRRKKVRRPF | 686 | Q6Y2X3 | |
| APTVPKKGRRKGRQA | 351 | Q96FI4 | |
| PGKRGRPRKLKLCKA | 611 | Q8IWI9 | |
| RPRKLKLCKAGRPPK | 616 | Q8IWI9 | |
| LKPRPGRKDRRKKGQ | 331 | P55107 | |
| KRGMLGKRPRRKSSR | 396 | O14782 | |
| KRRPRRQKPDPGVKI | 176 | Q9BRR8 | |
| KLRLPPERRGKGRSG | 146 | O15534 | |
| KGIPQRAPPKRKRKR | 266 | Q96MG8 | |
| NRGPKRPKVLQRGRL | 471 | Q8NCW6 | |
| GTRIRRKKPLGERPK | 106 | Q4G0J3 | |
| PQKRRRAKKARLLGP | 646 | Q8N9T8 | |
| IRRVVKGRPGPRKQK | 461 | Q8NAT1 | |
| KARPKTGRRKRSAKP | 676 | Q9Y496 | |
| RLKKRRKTPGPVLPK | 66 | P78563 | |
| RKIKGRGPRRYRTPS | 331 | Q13427 | |
| DQPIIIKRKRGRPRK | 2866 | Q8NFC6 | |
| AKDLPPKKRTRLGPR | 396 | Q8IV32 | |
| KRGKRPRGRPRKLTA | 71 | Q14781 | |
| LKDPIRKKRGRKPLP | 156 | Q14781 | |
| EQKRPLRPRRKGRKK | 1016 | Q9P2K1 | |
| PLTRKRSKKERGLRG | 36 | P57796 | |
| EGLRVKRGRLVPSPK | 3086 | P49454 | |
| DRRRKGLFGPPIGKK | 2121 | Q8TD57 | |
| DKKPKRRGRPRSVRK | 1111 | O14647 | |
| PAKGPARGAAKKRRL | 276 | A6NHQ4 | |
| RSKSPRVPDGRKKLR | 271 | Q12873 | |
| PVRTKKLKRGRPGRK | 341 | Q12873 | |
| SKGRRTLRKPKRVPS | 756 | Q8NHY3 | |
| ASGYRKRGPKPKRLL | 66 | O95931 | |
| AGARKKRRSPPRKRE | 76 | Q86UE4 | |
| PAKRGLLEKPLRTKR | 921 | P57679 | |
| VPRVGSRKLLRKSPR | 2256 | Q9BYK8 | |
| GRPKPLARKLRPAQK | 71 | Q8WTZ4 | |
| APKRKSVRRGRKPPL | 371 | Q99590 | |
| SVRRGRKPPLLKKKL | 376 | Q99590 | |
| TKRRGRPPLAKRDSK | 796 | Q6P995 | |
| RRLASPRGGKRPKKI | 11 | Q86V97 | |
| DSLKGRRGRLPSKPK | 336 | P43354 | |
| SLKGRRGRLPSKPKS | 366 | Q92570 | |
| GITPPLKNVRKKRFR | 221 | Q5H9L4 | |
| SPGQKKGRKDRRPRK | 201 | Q2I0M5 | |
| MGKKSRAVPGRRPIL | 1 | Q8N3X1 | |
| RPRAKRRPIVKTGKF | 101 | P58417 | |
| FLPPARKRKSKLGNR | 621 | Q5QGS0 | |
| KPRPRKTGRRKKDGV | 661 | Q14940 | |
| KRKRRPRGRGAKAPR | 626 | Q9Y2G9 | |
| KVRLIRGGSLPPVKR | 631 | Q13330 | |
| GPRRRGRKPTKAKRD | 1151 | Q9ULL5 | |
| KGRKPRPRARSAKAN | 191 | Q9BQB4 | |
| LKRRGPTSKKEPRKR | 396 | Q8IY92 | |
| VRPAKLPKGRGRLRR | 346 | Q7Z7L8 | |
| NKRPPKLGQIGRSKR | 41 | Q7Z7J9 | |
| VRKRSPAGLLRPKKG | 1921 | O15417 | |
| PQGALQTRRRKKKRP | 366 | Q6RFH5 | |
| PRGRKKKRMLESGLP | 191 | Q8TF68 | |
| GRGRGLPKKIKRKER | 216 | P61129 | |
| RPKGLEGKRPARLTR | 116 | Q9NQ39 | |
| RGPKRKLYSAVPGRK | 461 | Q9BYB0 | |
| AGPPTRKKSRRERKR | 511 | Q9H7N4 | |
| LPRLRLRKAKEKNGP | 601 | Q6UWL2 | |
| KANTRPLKRRRKRGP | 576 | P23497 | |
| PLKRRRKRGPRIPKD | 581 | P23497 | |
| PPRKDPRKRKARGGA | 1031 | Q96JG9 | |
| RRSVGGPQKTLKRPK | 196 | Q8N9P0 | |
| GRRRPEIGTFLRKKK | 336 | Q9H330 | |
| PRKGKRGRRPSKPRL | 126 | Q96CS4 | |
| RRRKKKGGPLRALSS | 336 | Q9H6Y2 | |
| GRLAKQKPKKRRRPD | 391 | P17010 | |
| AKRPRRELGSKGLKG | 941 | Q8N1G0 | |
| LKASLPRKRGRPPKS | 46 | Q96C55 | |
| RGRRKSVEPPKRKKR | 211 | Q9Y2D9 | |
| LSDVLKRKRLPKRGP | 996 | Q14669 | |
| KRKRLPKRGPRRPKY | 1001 | Q14669 | |
| PKGPAGKRGIRRLIR | 326 | Q12792 | |
| HRKVRRGGKPSPVLK | 526 | Q6AW86 | |
| NGLPRRRGLRKKKTT | 71 | Q96NK8 |